[1] Turelli P, Mangeat B, Jost S, et al. Inhibition of hepatitis B virus replication by APOBEC3G[J]. Science, 2004, 303 (5665):1829.[2] Zhao DJ, Wang XF, Lou GH, et al. APOBEC3G directly binds hepatitis B virus core protein in cell and cell free systems[J]. Virus Res, 2010, 151(2):213-219.[3] Baumert TF, Rosler C, Malim MH, et al. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C[J]. Hepatology, 2007, 46(3):682-689.[4] Guarnieri M, Kim KH, Bang G, et al. Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression[J]. J Virol, 2006, 80(2):587-595.[5] Rosler C, Kock J, Kann M, et al. APOBEC-mediated interference with hepadnavirus production[J]. Hepatology, 2005, 42(2):301-309.[6] Harris RS, Bishop KN, Sheehy AM, et al. DNA deamination mediates innate immunity to retroviral infection[J]. Cell, 2003, 113(6):803-809.[7] Navaratnam N, Sarwar R. An overview of cytidine deaminases [J]. Int J Hematol, 2006, 83(3):195-200.[8] Cullen BR. Role and mechanism of action of the APOBEC3 family of ntiretroviral resistance factors[J]. J Virol, 2006, 80(3):1067-1076.[9] Suspene R, Guetard D, Henry M, et al. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo[J]. Proc Natl Acad Sci USA, 2005, 102(23):8321-8326.[10] Nguyen DH, Gummuluru S, Hu J, et al. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G[J]. J Virol, 2007, 81(9):4465-4472.[11] Nguyen DH, Hu J. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids[J]. J Virol, 2008, 82(14):6852-6861.[12] Kim J, Park HC, Gedi V, et al. Yeast-hybrid based high-throughput assay for identification of anthraxlethal factor inhibitors[J]. Biochem Biophys Res Commun, 2011, 404(1):517-522.[13] Golemis EA, Brent R. Fused protein domains inhibit DNA binding by LexA[J]. Mol Cell Biol, 1992, 12(7):3006-3014. |